Skip to main content
. 2023 Feb 3;7(12):2872–2883. doi: 10.1182/bloodadvances.2022009019

graphic file with name BLOODA_ADV-2022-009019-fx1.jpg

Summary of BT modality, BT response and PFS post-CAR-T in all apheresed LBCL patients.